Bill Summary
The "Maintaining Innovation and Safe Technologies Act" is a legislative proposal that aims to facilitate the integration of artificial intelligence (AI) in healthcare, specifically within the Medicare program. The bill mandates that by January 1, 2027, the Secretary of Health and Human Services must provide clear guidance on how Medicare will reimburse for certain remote monitoring devices—such as continuous glucose monitors—that incorporate AI technology. These devices are designed to transmit health data to healthcare providers, aiding in the management and treatment of patients. The legislation seeks to ensure that the use of innovative AI-driven technologies in patient care is supported and that reimbursement processes are established to encourage their adoption.
Possible Impacts
The "Maintaining Innovation and Safe Technologies Act" could affect people in several ways:
1. **Improved Access to Advanced Healthcare Technologies**: With the legislation directing Medicare to provide guidance on payment for AI-assisted remote monitoring devices, beneficiaries could gain access to innovative health technologies, such as continuous glucose monitors. This could lead to better management of chronic conditions, improving patients' overall health and quality of life.
2. **Potential Reduction in Healthcare Costs**: By including AI components in healthcare devices and ensuring they are covered under Medicare, patients may face lower out-of-pocket costs for essential monitoring technologies. This could alleviate financial burdens for individuals managing chronic diseases, making healthcare more affordable and accessible.
3. **Enhanced Health Monitoring and Outcomes**: The use of AI in remote monitoring devices could result in more accurate and timely health data transmission to healthcare providers. This could lead to more personalized treatment plans and proactive management of health conditions, ultimately improving patient outcomes and reducing the need for emergency interventions or hospitalizations.
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 193 Introduced in House (IH)]
<DOC>
119th CONGRESS
1st Session
H. R. 193
To direct the Secretary of Health and Human Services to issue guidance
on payment under the Medicare program for certain items involving
artificial intelligence.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
January 3, 2025
Mr. Schweikert introduced the following bill; which was referred to the
Committee on Energy and Commerce, and in addition to the Committee on
Ways and Means, for a period to be subsequently determined by the
Speaker, in each case for consideration of such provisions as fall
within the jurisdiction of the committee concerned
_______________________________________________________________________
A BILL
To direct the Secretary of Health and Human Services to issue guidance
on payment under the Medicare program for certain items involving
artificial intelligence.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Maintaining Innovation and Safe
Technologies Act''.
SEC. 2. GUIDANCE ON MEDICARE PAYMENT FOR CERTAIN ITEMS INVOLVING
ARTIFICIAL INTELLIGENCE.
Not later than January 1, 2027, the Secretary of Health and Human
Services shall use existing communications mechanisms to issue guidance
on requirements for payment under part B of title XVIII of the Social
Security Act (42 U.S.C. 1395j et seq.) for remote monitoring devices,
such as continuous glucose monitors, that--
(1) use an artificial intelligence component (such as a
continuous adjustment component); and
(2) transmit information to a health care provider for
purposes of management and treatment of an individual.
<all>